Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 5.5% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 19,946 shares of the biopharmaceutical company’s stock after purchasing an additional 1,032 shares during the period. […]
Federated Hermes Inc. lowered its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 1.7% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 46,305 shares of the biopharmaceutical company’s stock after selling 804 shares during the period. Federated Hermes Inc.’s holdings in Alnylam Pharmaceuticals […]
Insider Selling: Alnylam Pharmaceuticals, Inc (NASDAQ:ALNY) CEO Sells $753,993 45 in Stock kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright reiterated their buy rating on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a research report sent to investors on Monday morning, Benzinga reports. The brokerage currently has a $405.00 target price on the biopharmaceutical company’s stock. A number of other research analysts have also recently commented on ALNY. William Blair reaffirmed […]
Royal Bank of Canada restated their outperform rating on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a research note published on Friday morning, Benzinga reports. The brokerage currently has a $270.00 price objective on the biopharmaceutical company’s stock. ALNY has been the subject of several other reports. StockNews.com raised Alnylam Pharmaceuticals from a […]